United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund
PensionPosition in GILD — Gilead Sciences, Inc.
CIK 1730896
MELBOURNE, C3
Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$45,279,750
-$5,645,490 QoQ
Shares Held
358,396
-1.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#220
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund holds $239,761,843 across 7 Drug Manufacturers - General names. GILD ranks #4 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
63,544 | $76,216,586 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,072,109 | $61,774,920 | |
| 3 | MRK |
Merck & Co., Inc.
|
393,305 | $50,539,692 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
358,396 | $45,279,750 | |
| 5 | ABBV |
AbbVie Inc.
|
17,700 | $4,454,028 | |
| 6 | AMGN |
Amgen Inc
|
2,240 | $811,148 | |
| 7 | JNJ |
Johnson & Johnson
|
2,700 | $685,719 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,279,750 | 358,396 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $50,925,240 | 365,396 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $55,244,783 | 450,096 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,808,300 | 25,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,208,483 | 10,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,098,090 | 9,800 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $249,399 | 2,700 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||